1. Home
  2. ACXP vs YMAT Comparison

ACXP vs YMAT Comparison

Compare ACXP & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.42

Market Cap

6.6M

Sector

Health Care

ML Signal

HOLD

Logo J-Star Holding Co. Ltd. Ordinary Shares

YMAT

J-Star Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$1.94

Market Cap

7.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACXP
YMAT
Founded
2017
1970
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
7.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
ACXP
YMAT
Price
$1.42
$1.94
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$95.50
N/A
AVG Volume (30 Days)
149.8K
41.1K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.92
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.24
52 Week High
$8.34
$6.45

Technical Indicators

Market Signals
Indicator
ACXP
YMAT
Relative Strength Index (RSI) 45.67 52.35
Support Level $1.36 $0.33
Resistance Level $1.79 $2.29
Average True Range (ATR) 0.13 0.19
MACD 0.01 -0.05
Stochastic Oscillator 21.69 40.08

Price Performance

Historical Comparison
ACXP
YMAT

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

About YMAT J-Star Holding Co. Ltd. Ordinary Shares

J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.

Share on Social Networks: